Prospective evaluation of fluorescence-in situ-hybridization to detect bladder cancer: Results from the UroScreen-Study

Urologic Oncology: Seminars and Original Investigations, 06/01/2012

Fluorescence–in–situ–hybridization showed a performance in detecting bladder cancer comparable to cytology but a larger number or false–positive results. It remains to be investigated if chromosomal instability can be detected earlier than morphologic changes of exfoliated bladder cancer cells.

Print Article Summary Cat 2 CME Report